Mutations in the tumor suppressor TP53 are a common cause of cancer, making the altered protein an attractive target for ...

Mutations in the tumor suppressor TP53 are a common cause of cancer, making the altered protein an attractive target for ...

Mutations in the tumor suppressor TP53 are a common cause of cancer, making the altered protein an attractive target for therapeutics. Among them, the Y220C mutation is the ninth most frequent and it ...

From new imaging and targeted therapies to patient journeys, 2025 highlighted key advances and personal stories in lung ...

The Eve appeal in partnership with North West Cancer Research, has awarded a third Fellowship to Dr Sarah Kitson, ...

The shocking revelations emerging from recent studies on COVID-19 vaccines are raising serious concerns about the safety and long-term effects of these mass vaccinations. A comprehensive review has ...

A new study by the National Cancer Research Center (CNIO) has identified several sets of genes related to the predisposition ...

A new study by the National Cancer Research Centre (CNIO) has identified several sets of genes related to the predisposition ...

Pancreatic cancer is notoriously hard to treat, often resisting therapies that target its most common mutations. Researchers ...

Changes in genes have been linked to the development of different diseases for a while. However, it's not exactly clear what ...

Researchers found in mice that multiple nutrients and cancer cell characteristics work together to control the spread of ...